Researchers used a sequencing method to find hidden small RNAs in the liver. They identified a molecule called tsRNA-Glu-CTC, which is very common in the liver and whose level changes with cholesterol.
In mice, higher tsRNA-Glu-CTC increased activity of SREBP2, the protein that controls cholesterol production, and so switched on genes that make cholesterol. When researchers used an antisense oligonucleotide (ASO) to block the molecule, mice had lower cholesterol and milder atherosclerosis. A naturally modified form of the molecule worked better than synthetic versions. Human blood tests showed people with higher tsRNA-Glu-CTC tended to have higher cholesterol. The finding could help new drugs that act earlier than current medicines.
Difficult words
- sequencing — a laboratory method to read DNA or RNA
- cholesterol — a fatty substance found in blood and cells
- antisense oligonucleotide — a short synthetic strand that blocks an RNA
- atherosclerosis — a disease where arteries become narrow with fat
- synthetic — made by people, not by living things
- switch on — to start a biological process or activityswitched on
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you or someone you know ever had a cholesterol blood test? What happened?
- Why might finding molecules that change with cholesterol help doctors?
- Would you prefer a medicine that works earlier than current drugs? Why or why not?
Related articles
Farming, breast milk and fewer food allergies
Researchers compared infants from Old Order Mennonite farm families and urban families in New York. Farm-exposed babies showed earlier immune maturation and higher antibodies, and breast milk antibody patterns were linked to lower egg allergy risk.
Antibiotics on farms and rising resistance in East Africa
Antibiotic use on farms in parts of East Africa is increasing antimicrobial resistance. Poor access to veterinary care, weak rules and routine drug use on animals are driving resistant infections that affect people, animals and the environment.
PAHO issues first guide for tungiasis treatment
PAHO has published the first evidence-based guide to treat tungiasis, recommending low-viscosity dimethicone and warning against unsafe manual removal. The disease affects millions in Latin America, the Caribbean and Sub-Saharan Africa.
